Hugo Turner


United Kingdom
Imperial College London, UK


Dr Turner’s research focuses on health economic analyses of infectious diseases in low and middle-income countries. He specializes in performing costings of healthcare interventions, cost of illness analysis and cost-effectiveness analysis. He is also trained in developing and using disease transmission models and using models to evaluate the impact of interventions. A particular focus of his work are diseases associated with poverty (such as the neglected tropical diseases). 

Between 2016-2019 his role was to establish and lead a health economics group within the Oxford University Clinical Research Unit in Vietnam. As of 2020, he will be taking a faculty position within the School of Public Health, Imperial College London. For his full bio, please see here

5 Answers
5 related questions found.

Is life year gained (LYG) estimate suitable for use with the WHO threshold?

We did a cost-effectiveness study of a program using LiST spectrum. We have reported our findings in cost per life year gained (LYG). Is it possible to compare the cost per LYG with the WHO GDP/capita threshold? The GDP/capita of the WHO is in cost per DALY. Or, is there a way to convert LYG to DALY...

Asked: 07 Sep 2019  |   1109  |   3 answers


For instance, the equipment was bought in 2017 and its lifespan is 10 years, I want to calculate the cost of this equipment for 2019. How do I annulize the cost of medical equipment? Do I need to convert the cost of equipment to current year using CPI before annulizing the cost or annulize directl...

Asked: 13 Dec 2019  |   959  |   2 answers

estimating real income and comparing to Int. Dollar

I was doing an article on real income of health workers in Ethiopia. I have average annual salary of 14 years. so, I want to see whether the salary increase over year or not compared to GDP per capita. I decided to use the GDP per capita in 2011 constant international dollar. I have the data now. 1...

Asked: 16 Feb 2020  |   811  |   1 answer

ICER threshold

I am doing my master thesis on the model-based cost-effectiveness of cardiovascular risk screening program in Zambia. P: population in Zambia age 40 - 79 years old I: non-laboratory-based WHO CVD risk chart and laboratory-based WHO CVD risk chart C: no screening, comparison between non-laboratory-ba...

Asked: 25 Dec 2023  |   182  |   1 answer

Determining Discount Factors

How do we determine discount factors. Whether there should be different discount factors for different conditions?

Asked: 17 Jan 2024  |   161  |   1 answer